2017

Helping beta cells divide

March 17, 2017

 

Scientists identify a key barrier to proliferation of inuslin-producing cells

If you become resistant to insulin, a condition that is a precursor to type 2 diabetes, your body tries to compensate by producing more of the “beta” cells in the pancreas that produce the critical hormone. Researchers have long sought to understand why these cells often fail to proliferate in people who go on to develop the disease. Studying both humans and mice, scientists at Joslin Diabetes Center now have pinpointed one key biological mechanism that can prevent...

Read more about Helping beta cells divide
Headshot of man wearing light blue shirt and dark blue tie smiling at camera with a whiteboard in the background

Khalid Shah, M.S., Ph.D.

Vice Chair of Research, Department of Neurosurgery, Brigham and Women's Hospital
Director, Center for Stem Cell and Translational Immunotherapy, Brigham and Women's Hospital
Professor, Harvard Medical School

The Shah lab seeks to develop and test novel, targeted, cell-based therapies for brain cancers.

Successful treatment of brain tumors...

Read more about Khalid Shah, M.S., Ph.D.
Sridhar Ramaswamy, MD

HSCI Alumni: Sridhar Ramaswamy, MD

Senior VP for Research and Development, Tesaro, Inc.

Metastatic cancers are the major reason for treatment failure in the clinic, but we lack a detailed understanding of how primary tumors metastasize, why these secondary tumors are relatively drug resistant, and what enables cancer cells to remain dormant and then cause disease relapse many years after apparently curative treatment. We are taking a multidisciplinary approach to attack these fundamental and related problems. Our major goal is to identify important cancer gene networks that are essential in human cancer progression, to guide the development and clinical use of new cancer drugs and diagnostics.... Read more about Sridhar Ramaswamy, MD

Pages